Effect of Docosa-Hexanoic Acid (DHA) Supplements During Pregnancy on Newborn Outcomes in India. (DHANI)
Effect of Docosa-Hexanoic Acid (DHA) Supplements During Pregnancy on Newborn Outcomes in India (DHANI)
Sponsor: Centre for Chronic Disease Control, India
Listed as NCT01580345, this PHASE3 trial focuses on Pregnancy and remains completed. Sponsored by Centre for Chronic Disease Control, India, it has been updated 7 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 2 earlier versions
-
May 2017 — Jun 2018 [monthly]
Completed PHASE3
Status: Recruiting → Completed
-
Jan 2017 — May 2017 [monthly]
Recruiting PHASE3
First recorded
Dec 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre for Chronic Disease Control, India
- Department of Science and Technology, Government of India
- Jawaharlal Nehru Medical College
For direct contact, visit the study record on ClinicalTrials.gov .